Baidu
map

肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2020 KSUR共识声明：经直肠超声引导下前列腺活检指南

2020-03-20 韩国泌尿生殖放射学学会 Korean J Radiol. 2020 Apr;21(4):422-430.

超声引导前列腺活检经直肠超声引导下前列腺活检

2020年韩国泌尿生殖放射学学会(KSUR)发布了经直肠超声引导下前列腺活检指南，内容涉及患者准备，技术标准，疼痛管理等。

中文标题：

2020 KSUR共识声明：经直肠超声引导下前列腺活检指南

英文标题：

Guidelines for Transrectal Ultrasonography-Guided Prostate Biopsy: Korean Society of Urogenital Radiology Consensus Statement for Patient Preparation, Standard Technique, and Biopsy-Related Pain Management.

发布机构：

韩国泌尿生殖放射学学会

发布日期：

2020-03-20

简要介绍：

2020年韩国泌尿生殖放射学学会(KSUR)发布了经直肠超声引导下前列腺活检指南，内容涉及患者准备，技术标准，疼痛管理等。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=)] GetToolGuiderByIdResponse(projectId=1, id=35aae1c001885128, title=2020 KSUR共识声明：经直肠超声引导下前列腺活检指南, enTitle=Guidelines for Transrectal Ultrasonography-Guided Prostate Biopsy: Korean Society of Urogenital Radiology Consensus Statement for Patient Preparation, Standard Technique, and Biopsy-Related Pain Management., guiderFrom=Korean J Radiol. 2020 Apr;21(4):422-430., authorId=0, author=, summary=2020年韩国泌尿生殖放射学学会(KSUR)发布了经直肠超声引导下前列腺活检指南，内容涉及患者准备，技术标准，疼痛管理等。, cover=https://img.medsci.cn/Random/OIP.jpg, journalId=0, articlesId=null, associationId=1891, associationName=韩国泌尿生殖放射学学会, associationIntro=韩国泌尿生殖放射学学会(KSUR,Korean Society of Urogenital Radiology), copyright=0, guiderPublishedTime=Fri Mar 20 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年韩国泌尿生殖放射学学会(KSUR)发布了经直肠超声引导下前列腺活检指南，内容涉及患者准备，技术标准，疼痛管理等。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=23306, tagName=超声引导), TagDto(tagId=39911, tagName=前列腺活检), TagDto(tagId=91610, tagName=经直肠超声引导下前列腺活检)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=942, guiderKeyword=前列腺, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1749, appHits=115, showAppHits=0, pcHits=446, showPcHits=1714, likes=0, shares=5, comments=9, approvalStatus=1, publishedTime=Mon Mar 30 00:50:08 CST 2020, publishedTimeString=2020-03-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Mon Mar 30 00:02:34 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 01:09:18 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=)])
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2092382, encodeId=34c5209238213, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae6f1876308, createdName=ms7122239318790137, createdTime=Fri Oct 07 23:48:34 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969787, encodeId=3667969e87d5, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd4b5484443, createdName=迷你🐷, createdTime=Mon May 31 09:13:50 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949392, encodeId=e0f4949392cb, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210318/735dcd8067894e549298eaf505f503b3/5c5ca49e66c54289ace106d010d9c1b2.jpg, createdBy=31de2386805, createdName=12325e77m96暂无昵称, createdTime=Thu Mar 18 23:44:41 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903706, encodeId=ac31903e0673, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7b5432196, createdName=ms7000000487567332, createdTime=Mon Nov 30 23:07:16 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903662, encodeId=7626903662e7, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7b5432196, createdName=ms7000000487567332, createdTime=Mon Nov 30 21:44:56 CST 2020, time=2020-11-30, status=1, ipAttribution=)]
    2022-10-07 ms7122239318790137

    非常实用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2092382, encodeId=34c5209238213, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae6f1876308, createdName=ms7122239318790137, createdTime=Fri Oct 07 23:48:34 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969787, encodeId=3667969e87d5, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd4b5484443, createdName=迷你🐷, createdTime=Mon May 31 09:13:50 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949392, encodeId=e0f4949392cb, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210318/735dcd8067894e549298eaf505f503b3/5c5ca49e66c54289ace106d010d9c1b2.jpg, createdBy=31de2386805, createdName=12325e77m96暂无昵称, createdTime=Thu Mar 18 23:44:41 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903706, encodeId=ac31903e0673, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7b5432196, createdName=ms7000000487567332, createdTime=Mon Nov 30 23:07:16 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903662, encodeId=7626903662e7, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7b5432196, createdName=ms7000000487567332, createdTime=Mon Nov 30 21:44:56 CST 2020, time=2020-11-30, status=1, ipAttribution=)]
    2021-05-31 迷你🐷

    好东西

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2092382, encodeId=34c5209238213, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae6f1876308, createdName=ms7122239318790137, createdTime=Fri Oct 07 23:48:34 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969787, encodeId=3667969e87d5, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd4b5484443, createdName=迷你🐷, createdTime=Mon May 31 09:13:50 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949392, encodeId=e0f4949392cb, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210318/735dcd8067894e549298eaf505f503b3/5c5ca49e66c54289ace106d010d9c1b2.jpg, createdBy=31de2386805, createdName=12325e77m96暂无昵称, createdTime=Thu Mar 18 23:44:41 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903706, encodeId=ac31903e0673, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7b5432196, createdName=ms7000000487567332, createdTime=Mon Nov 30 23:07:16 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903662, encodeId=7626903662e7, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7b5432196, createdName=ms7000000487567332, createdTime=Mon Nov 30 21:44:56 CST 2020, time=2020-11-30, status=1, ipAttribution=)]
    2021-03-18 12325e77m96暂无昵称

    好东西

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2092382, encodeId=34c5209238213, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae6f1876308, createdName=ms7122239318790137, createdTime=Fri Oct 07 23:48:34 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969787, encodeId=3667969e87d5, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd4b5484443, createdName=迷你🐷, createdTime=Mon May 31 09:13:50 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949392, encodeId=e0f4949392cb, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210318/735dcd8067894e549298eaf505f503b3/5c5ca49e66c54289ace106d010d9c1b2.jpg, createdBy=31de2386805, createdName=12325e77m96暂无昵称, createdTime=Thu Mar 18 23:44:41 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903706, encodeId=ac31903e0673, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7b5432196, createdName=ms7000000487567332, createdTime=Mon Nov 30 23:07:16 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903662, encodeId=7626903662e7, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7b5432196, createdName=ms7000000487567332, createdTime=Mon Nov 30 21:44:56 CST 2020, time=2020-11-30, status=1, ipAttribution=)]
    2020-11-30 ms7000000487567332

    很有用

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2092382, encodeId=34c5209238213, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae6f1876308, createdName=ms7122239318790137, createdTime=Fri Oct 07 23:48:34 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969787, encodeId=3667969e87d5, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd4b5484443, createdName=迷你🐷, createdTime=Mon May 31 09:13:50 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949392, encodeId=e0f4949392cb, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210318/735dcd8067894e549298eaf505f503b3/5c5ca49e66c54289ace106d010d9c1b2.jpg, createdBy=31de2386805, createdName=12325e77m96暂无昵称, createdTime=Thu Mar 18 23:44:41 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903706, encodeId=ac31903e0673, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7b5432196, createdName=ms7000000487567332, createdTime=Mon Nov 30 23:07:16 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903662, encodeId=7626903662e7, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7b5432196, createdName=ms7000000487567332, createdTime=Mon Nov 30 21:44:56 CST 2020, time=2020-11-30, status=1, ipAttribution=)]
    2020-11-30 ms7000000487567332

    很有用

    0

相关指南

2018 临床实践指南：内镜超声/超声引导下胆道引流的安全操作

国外消化科相关专家小组（统称） · 2019-07-30

拓展阅读

2014 EAU 非神经源性男性下尿路症状（LUTS）包括良性前列腺梗阻（BPO）管理指南

欧洲泌尿外科学会(EAU,European Association of Urology) · 2014-04-01

2016 AUA/SAR共识声明：先前活检阴性患者前列腺MRI检查和MRI定向活检  

美国泌尿外科学会(AUA,American Urological Association) · 2016-06-16

2017 EANM/SNMMI指南：前列腺癌68Ga-PSMA PET/CT检查

欧洲核医学协会(EANM,European Association of Nuclear Medicine) · 2017-03-10

2017前列腺癌筛查专家共识

中国抗癌协会泌尿肿瘤专业委员会 · 2017-05-03

【专题】前列腺疾病不可怕，尽早治疗是关键！

暂未更新 · 2017-05-15

2017 AUA/ASTRO/SUO指南：临床局限性前列腺癌

美国泌尿外科学会(AUA,American Urological Association) · 2017-05-10

Baidu
map
Baidu
map
Baidu
map